STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Drugs Made In America Acquisition II Stock Price, News & Analysis

DMIIU NASDAQ

Company Description

Welcome to the overview page for Drugs Made In America Acquisition II (DMIIU), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year

Financial Highlights

$46,158
Net Income (TTM)
$703,367
Operating Cash Flow
Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Drugs Made In America Acquisition II (DMIIU)?

The current stock price of Drugs Made In America Acquisition II (DMIIU) is $10 as of December 2, 2025.

What is the net income of Drugs Made In America Acquisition II (DMIIU)?

The trailing twelve months (TTM) net income of Drugs Made In America Acquisition II (DMIIU) is $46,158.

What is the earnings per share (EPS) of Drugs Made In America Acquisition II (DMIIU)?

The diluted earnings per share (EPS) of Drugs Made In America Acquisition II (DMIIU) is $0.00 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Drugs Made In America Acquisition II (DMIIU)?

The operating cash flow of Drugs Made In America Acquisition II (DMIIU) is $703,367. Learn about cash flow.

What is the current ratio of Drugs Made In America Acquisition II (DMIIU)?

The current ratio of Drugs Made In America Acquisition II (DMIIU) is 1.32, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Drugs Made In America Acquisition II (DMIIU)?

The operating income of Drugs Made In America Acquisition II (DMIIU) is $155,513. Learn about operating income.